- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05619588
Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only
February 23, 2024 updated by: Exactech
An Open Label, Multi-Center, Single Arm Prospective Evaluation of Exactech Vantage Total Ankle System
The objectives of this study are to evaluate the performance and safety of the Vantage Total Ankle System.
This study will follow subjects for a period of up to 10 years post-surgery.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Estimated)
370
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sandrine Angibaud
- Phone Number: 352-377-1140
- Email: sandrine.angibaud@exac.com
Study Contact Backup
- Name: Rachael Craig
- Phone Number: 352-377-1140
- Email: rachael.craig@exac.com
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27703
- Recruiting
- Duke University Medical Center
-
Contact:
- Amanda Roberston
- Phone Number: 919-584-9493
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients who meet eligibility criteria - Patients who consent to participate to return for follow-up visits out to 10 years or longer
Description
Inclusion Criteria:
- Patient is indicated for total ankle arthroplasty
- Patient is skeletally mature
- Patient is mentally capable of completing follow-up forms
- Patient will be available for follow-up out to 10 years
- Patient has been deemed a candidate for Ankle replacement by diagnosis of the investigator
- Patient is willing and able to read and sign a study informed consent form
Exclusion Criteria:
- Patient with excessive bone loss at the ankle joint site
- Patient with severe osteoporosis
- Patient with complete talar avascular necrosis
- Patient with Active Osteomyelitis
- Patient with Infection at the ankle site or infection at distant sites that could migrate to the ankle
- Patient with Sepsis
- Patient with Vascular deficiency in the involved limb
- Patient with Neuromuscular inadequacy (e.g. Prior paralysis, fusion and or inadequate abductor strength)
- Patient with Neuropathic joints
- Patient with Neurological or musculoskeletal disease or loss of function that may adversely affect movement of the lower limb, gait, or weight bearing
- Patient with Poor soft tissue coverage around the ankle
- Patient with Charcot arthropathy
- Previous ankle arthrodesis with excision of the malleoli
- Excessive loads as caused by activity or patient weight - per investigator discretion
- Skeletally immature patients (patient is less than 21 years if age at time of surgery)
- Patient with dementia
- Patient with known metal allergies
- Patient who is pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
AOFAS
Time Frame: Through study completion, an average of 1 per year
|
American Orthopedic Foot and Ankle Society Score (AOFAS) - Questionaire on pain (40 points), function (45 points) , and alignment (15 points) - 100 points score where 100 indicates a healthy midfoot
|
Through study completion, an average of 1 per year
|
SMFA
Time Frame: Through study completion, an average of 1 per year
|
Short Musculoskeletal Function Assessment (SMFA) Score - 46 items Patient questionnaire divided into two sections: 34 questions on patients function assessment and 12 questions covering how bothered patients are by their symptoms where 1 indicates no problems/no difficulty/ not bothered and 5 indicates unable to do/symptoms all the time/being greatly bothered
|
Through study completion, an average of 1 per year
|
SF-36
Time Frame: Through study completion, an average of 1 per year
|
Short Form Health Survey (SF-36) Score - 36-item patient-reproted survey of patient health - It consists on 8 scales: Physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health.
Each scale is transformed into a 0-100 scale where the lower score indicates the more disability and the higher score the lest disability
|
Through study completion, an average of 1 per year
|
Sports Frequency Score
Time Frame: Through study completion, an average of 1 per year
|
Sports Frequency Score - Level of sport activity in leisure time where 0 indicates "no sports activity" and 4 indicates "professional level of sports activity, elite athlete
|
Through study completion, an average of 1 per year
|
VAS Pain and Patient Satisfaction Score
Time Frame: Through study completion, an average of 1 per year
|
Visual Analog Scale (VAS) Score - Range of scores from 0-100 to indicate level of pain - Higher score indicates greater pain intensity
|
Through study completion, an average of 1 per year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 4, 2017
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
September 30, 2031
Study Registration Dates
First Submitted
November 9, 2022
First Submitted That Met QC Criteria
November 9, 2022
First Posted (Actual)
November 17, 2022
Study Record Updates
Last Update Posted (Estimated)
February 26, 2024
Last Update Submitted That Met QC Criteria
February 23, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR16-002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ankle Rheumatoid Arthritis
-
Orthopaedic Associates of Michigan, PCCompletedRheumatoid Arthritis of Ankle | Osteoarthritis of Ankle | Traumatic Arthritis of AnkleUnited States
-
Peking University Third HospitalUnknownRheumatoid Arthritis of AnkleChina
-
ExactechRecruitingRheumatoid Arthritis | Arthritis of Ankle | Failure, ProsthesisSpain, Switzerland
-
Smith & Nephew, Inc.CompletedOsteoarthritis | Rheumatoid Arthritis | Septic Arthritis | Post-Traumatic Arthritis | Prior Ankle FusionUnited States
-
University Medical Centre LjubljanaUnknownInstability; Ankle (Ligaments) (Old Injury) | Ankle Arthritis | Osteochondral Lesion of Talus | Impingement Syndrome of AnkleSlovenia
-
MedShape, IncOrthopedic Foot and Ankle Center, Ohio; CurveBeam LLCRecruitingAnkle Arthritis | Arthritis FootUnited States
-
Assiut UniversityUnknown
-
Unity Health TorontoUnknown
-
Ross LeightonJohnson & Johnson; Nova Scotia Health Authority; Canadian Orthopaedic Foot and...Unknown
-
Columbia Orthopaedic Group, LLPTerminated